Cameron Brooks Biography and Net Worth

CRO of Axon Enterprise

Cameron Brooks is an accomplished global executive with a track record of successfully developing high-performance sales teams and growing technology businesses internationally. He currently serves as Chief Revenue Officer at Axon, where he is responsible for the strategy and execution of all sales and services at the company. Prior to joining Axon, Cameron was General Manager of Europe, Middle East and Africa Public Sector for Amazon Web Services. He spent 6 years at AWS and grew the business across Europe and the Middle East by cultivating partnerships with government, education, and healthcare clients to enable their transformation through cloud computing.

Cameron has over 25 years of experience in the industry. He has successfully leveraged his strong technology background to become a global expert and thought leader in areas such as Cloud, AI, Healthcare, Smart Cities and Supercomputing, and then guide clients along a journey of digital transformation. Prior to AWS, Cameron spent 20 years at IBM where he served in key roles such as Director of Public Sector for IBM’s Watson Group, Public Sector Leader for IBM’s Middle East & Africa organization, and the Director of IBM’s Government Healthcare business.

Cameron holds a BS degree in Electrical Engineering from the University of Waterloo, Canada, and MS and PhD degrees in Electrical Engineering from the University of Michigan. He also holds an MBA degree from the New York University Stern School of Business.

What is Cameron Brooks' net worth?: The estimated net worth of Cameron Brooks is at least $10.71 million as of May 30th, 2025. Mr. Brooks owns 19,447 shares of Axon Enterprise stock worth more than $10,707,713 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Brooks may own. Learn More about Cameron Brooks' net worth.
How do I contact Cameron Brooks?: The corporate mailing address for Mr. Brooks and other Axon Enterprise executives is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. Axon Enterprise can also be reached via phone at (480) 991-0797 and via email at [email protected]. Learn More on Cameron Brooks' contact information.
Has Cameron Brooks been buying or selling shares of Axon Enterprise?: Cameron Brooks has not been actively trading shares of Axon Enterprise during the last ninety days. Most recently, Cameron Brooks sold 3,000 shares of the business's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $740.76, for a transaction totalling $2,222,280.00. Following the completion of the sale, the executive now directly owns 19,447 shares of the company's stock, valued at $14,405,559.72. Learn More on Cameron Brooks' trading history.
Who are Axon Enterprise's active insiders?: Axon Enterprise's insider roster includes Jawad Ahsan (CFO), Brittany Bagley (CFO), Cameron Brooks (CRO), Adriane Brown (Director), Julie Cullivan (Director), Michael Garnreiter (Director), Joshua Isner (CRO), Caitlin Kalinowski (Director), Mark Kroll (Director), Jeffrey Kunins (Insider), Luke Larson (President), Matthew McBrady (Director), Hadi Partovi (Director), Patrick Smith (Co-Founder, CEO & Director), and Jeri Williams (Director). Learn More on Axon Enterprise's active insiders.
Are insiders buying or selling shares of Axon Enterprise?: In the last year, Axon Enterprise insiders bought shares 1 times. They purchased a total of 1,358 shares worth more than $1,004,920.00. In the last year, insiders at the biotechnology company sold shares 34 times. They sold a total of 127,700 shares worth more than $89,444,928.79. The most recent insider tranaction occured on December, 3rd when President Joshua Isner sold 2,041 shares worth more than $1,092,159.51. Insiders at Axon Enterprise own 4.4% of the company. Learn More about insider trades at Axon Enterprise.
Information on this page was last updated on 12/3/2025.

Cameron Brooks Insider Trading History at Axon Enterprise

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/30/2025	Sell	3,000	$740.76	$2,222,280.00	19,447

Cameron Brooks Buying and Selling Activity at Axon Enterprise

Axon Enterprise Company Overview

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include axon officer safety plan; taser 10, taser7, taser X26P, taser X2, taser 7 CQ, and civilian series; cameras, such as axon body, axon flex, axon fleet, axon air, axon signal sidearm, axon signal vehicle, axon interview, and axon interview portable kit; software, including axon records, evidence, standards, commander, performance, auto-transcribe, justice, investigate, respond, and justice, my90, and redaction assistant; mobile applications, and training services, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. The company sells its products through its direct sales, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand bility to aggregate live video, data, and sensor feeds. It serves law enforcement, federal, correction, fire, EMS, campus, justice healthcare, retail, private security, and personal safety industries. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Today's Range

Now: $550.61

$540.65

$553.46

50 Day Range

MA: $642.45

$519.61

$759.44

2 Week Range

Now: $550.61

$469.24

$885.91

Volume

1,259,007 shs

Average Volume

872,295 shs

Market Capitalization

$43.45 billion

P/E Ratio

174.24

Dividend Yield

N/A

Beta

1.4